CLINICAL RESEARCH: GENETICS/GENOMICS
Neuropeptide Y1 Receptor NPY1RDiscovery of Naturally Occurring Human Genetic Variants Governing Gene Expression In Cella as Well as Pleiotropic Effects on Autonomic Activity and Blood Pressure In Vivo
Lei Wang, MD*,
Fangwen Rao, MD*,
Kuixing Zhang, MD, PhD*,
Manjula Mahata, PhD*,
Juan L. Rodriguez-Flores, PhD*,
Maple M. Fung, MD*, ,
Jill Waalen, MD ,
Myles G. Cockburn, PhD||,
Bruce A. Hamilton, PhD*,
Sushil K. Mahata, PhD*, and
Daniel T. O'Connor, MD*, , ,*
* Department of Medicine, University of California at San Diego, California
Department of Pharmacology, University of California at San Diego, California
VA San Diego Healthcare System, San Diego, California
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California
|| Department of Preventive Medicine, USC Keck School of Medicine, Los Angeles, California
Manuscript received February 17, 2009;
revised manuscript received May 13, 2009,
accepted May 14, 2009.
* Reprint requests and correspondence: Dr. Daniel T. O'Connor, Department of Medicine, UCSD School of Medicine, 9500 Gilman Drive, La Jolla, California 92093-0838 (Email: doconnor{at}ucsd.edu).
Objectives: We asked whether naturally occurring genetic variation at the human NPY1R locus alters autonomic traits that might predispose individuals to cardiovascular disease.
Background: Neuropeptide Y (NPY) interacts with the Y1 receptor, NPY1R, to control adrenergic activity and blood pressure (BP).
Methods: We searched for polymorphism at NPY1R by systematic resequencing in ethnically diverse people. There were 376 twins/siblings who were evaluated for heritable autonomic traits: baroreflex function and pressor response to environmental stress.
Results: The common NPY1R variant A+1050G in the 3'-untranslated region (3'-UTR) predicted baroreceptor slope (p = 0.014–0.047) and BP change to cold stress (p = 0.0091–0.016), with minor allele homozygotes displaying blunted slope and exaggerated pressor response. In 936 individuals with the most extreme BPs in the population, not only 3'-UTR A+1050G (p = 1.2 x 10–4) but also promoter A-585T (p = 0.001) affected both systolic BP and diastolic BP, in interactive fashion (p = 0.007), with combined homozygotes showing the highest diastolic BP (>20 mm Hg). The 3'-UTR variant +1050G decreased expression of a transfected luciferase reporter/NPY1R 3'-UTR plasmid; promoter variant A-585 also decreased expression of an NPY1R promoter/luciferase reporter. Thus, alleles that increased BP in vivo (3'-UTR +1050G, promoter A-585) also decreased NPY1R expression in cella. Computational alignment showed that A+1050G disrupted a microRNA motif.
Conclusions: Our results indicate that naturally occurring genetic variation at the NPY1R locus has implications for heritable autonomic control of the circulation, and ultimately, for systemic hypertension. The findings suggest novel pathophysiological links between the NPY1R locus, autonomic activity, and blood pressure, and suggest new strategies to approach the mechanism, diagnosis, and treatment of systemic hypertension.
Key Words: hypertension neuropeptide genetics
|
Abbreviations and Acronyms
| | BP = blood pressure | | DBP = diastolic blood pressure | | Del = deletion | | h2
= heritability | | HR = heart rate | | Ins = insertion | | LD = linkage disequilibrium | | NPY = neuropeptide Y | | NPY1R = neuropeptide Y1 receptor | | SBP = systolic blood pressure | | SNP = single nucleotide polymorphism | | UTR = untranslated region |
|
Related Article
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A29.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, et al.
Highlights of the Year in JACC 2009
J. Am. Coll. Cardiol.,
January 26, 2010;
55(4):
380 - 407.
[Full Text]
[PDF]
|
 |
|
|